Fabry Disease Market Research Reports & Industry Analysis
Fabry Disease Industry Research & Market Reports
-
Fabry Disease Treatment
... at a CAGR of 8.2% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$1.7 Billion by the end ... Read More
-
Fabry Disease Treatment Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Fabry Disease - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Fabry Disease Understanding Fabry Disease: ... Read More
-
Fabry Disease Treatment Market Size, Share, and Outlook, 2025 Report- By Treatment (Enzyme Replacement Therapy, Oral Chaperone Therapy, Others), By Route of Aministration, Oral Route, Intravenous Route), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Fabry Disease Treatment segments across 22 countries ... Read More
-
Enzyme Replacement Therapy Market Size, Share, and Outlook, 2025 Report- By Product (Agalsidase Beta, Imiglucerase , Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others), By Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI), Others), By End-User (Hospitals, Infusion Centers & Home Healthcare Setting), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Enzyme Replacement Therapy segments across 22 countries ... Read More
-
Neurometabolic Disorders Market Size, Share, and Outlook, 2025 Report- By Types (Fabry disease, Niemann-pick Type C Disease, Gaucher's Disease, Pompe Disease, Mucopolysaccharidosis VI), By Route of Administration (Parenteral, Oral), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurometabolic Disorders segments across 22 countries from 2021 to 2032. ... Read More
-
Fabry Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
... treatments for Fabry disease is driving market expansion worldwide. The condition, a rare genetic disorder caused by mutations in the GLA gene, leads to the buildup of harmful fatty substances in various organs, resulting in ... Read More
-
Fabry Disease Market Report by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033
... USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.02% during 2025-2033. The increasing number of patients suffering from ... Read More
-
Fabry Disease Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type
... CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030. For geography segment, regional supply, demand, major players, price is presented from ... Read More
-
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications
... during the forecast period 2024-2035. Rare kidney diseases encompass a spectrum of conditions, accounting to at least 150 distinct disorders. In Europe, a condition is deemed rare if its prevalence falls below 1 in 2000 ... Read More
-
Lysosomal Storage Disease Treatment Market Size, Trends, Analysis, and Outlook By Therapy (Enzyme Replacement Therapy, Substrate Reduction Therapy), By Application (Gaucher disease, Cystinosis, Pompe Disease, Fabry Disease, Others), by Country, Segment, and Companies, 2024-2032
... global Lysosomal Storage Disease Treatment market size is poised to register 8.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Lysosomal Storage ... Read More
-
Neurometabolic Disorders Market Size, Trends, Analysis, and Outlook By Types (Fabry disease, Niemann-pick Type C Disease, Gaucher's Disease, Pompe Disease, Mucopolysaccharidosis VI), By Route of Administration (Parenteral, Oral), by Region, Country, Segment, and Companies, 2024-2030
... The global Neurometabolic Disorders market size is poised to register 6.15% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurometabolic Disorders market ... Read More
-
Enzyme Replacement Therapy Market Size, Trends, Analysis, and Outlook By Product (Agalsidase Beta, Imiglucerase , Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others), By Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI), Others), By End-User (Hospitals, Infusion Centers & Home Healthcare Setting), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Hospitals, Infusion Centers & Home Healthcare Setting), by Region, Country, Segment, and Companies, 2024-2030 The global Enzyme Replacement Therapy market size is poised to register 6.84% growth from 2024 to 2030, presenting significant ... Read More
-
The 2025-2030 World Outlook for Fabry Disease Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Orphan Disease Therapeutics in Genetics Disorders
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Enzyme Replacement Therapy Market by Therapeutic Condition (Fabry Disease, Gaucher Disease, Mucopolysaccharidosis), Enzyme Type (Agalsidase Beta, Alglucosidase Alfa, Galsulfase), Route of Administration, End-User - Global Forecast 2024-2030
... at USD 8.09 billion in 2023 and expected to reach USD 8.87 billion in 2024, at a CAGR 9.80% to reach USD 15.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Fabry Disease Treatment Market by Treatment Type (Chaperone Treatment, Enzyme Replacement Therapy, Organ-Specific Treatment), Drugs (Agalsidase Beta, Migalastat, Pipeline Drugs), Route of Administration - Global Forecast 2024-2030
... at USD 2.50 billion in 2023 and expected to reach USD 2.71 billion in 2024, at a CAGR 8.47% to reach USD 4.41 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030
... size was estimated at USD 9.31 billion in 2023 and expected to reach USD 9.98 billion in 2024, at a CAGR 7.48% to reach USD 15.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Global Fabry Disease Drugs Market 2024-2028
... fabry disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Fabry Disease Treatment Market - 2023-2030
... 2030. The global Fabry disease treatment market is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030). The key market trend is the increasing focus on precision medicine and personalized therapies. For ... Read More
-
Plant-Based Biologics Market By Product Type (Leaf-based, Seed-Based, Fruit-based, Others), By Source (Carrot, Tobacco, Rice, Duckweed, Others), By Target Disease (Gaucher Disease, Fabry Disease, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... biologics market is envisioned to garner $182.9 million by 2031, growing from $116.1 million in 2021 at a CAGR of 4.8% from 2022 to 2031. The current production platforms, which are mostly based on mammalian ... Read More
-
Fabry Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Fabry Disease pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
Research Assistance
